Trial Profile
Phacoemulcification with intravitreal bevacizumab injection in patients with cataract and coexisting diabetic retinopathy: Prospective randomized study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy; Glaucoma
- Focus Therapeutic Use
- 09 Aug 2012 New trial record